Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences cash dividends declared ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity
Latest, FY2022
3,725
Period ended Dec 31, 2022
Change on a year earlier
+3.0%
3,618 in FY2021
History
8 years
Since FY2015
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash dividends declared ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 3,725 | +3.0% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 3,618 | +4.4% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 3,464 | +6.9% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 3,239 | +8.5% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 2,986 | +8.9% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 2,742 | +11.2% | Form 10-K (filed 2019-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 2,465 | +30.4% | Form 10-K (filed 2018-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 1,890 | – | Form 10-K (filed 2017-02-27) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Cash dividends declared ($M) ($M), annual FY2015–FY2022 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/cap_div_decl_tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.